Page 715 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 715

CHAPTER 38  Thyroid & Antithyroid Drugs     701


                     SUMMARY Drugs Used in the Management of Thyroid Disease


                                            Mechanism of Action                                Pharmacokinetics, Toxicities,
                     Subclass, Drug         and Effects              Indications               Interactions
                     THYROID PREPARATIONS                                                       
                     •  Levothyroxine (T 4 )  Activation of nuclear receptors   Hypothyroidism  See Table 38–1 • maximum effect seen
                     •  Liothyronine (T 3 )  results in gene expression with RNA               after 6–8 weeks of therapy • Toxicity: See
                                            formation and protein synthesis                    Table 38–4 for symptoms of thyroid excess

                     ANTITHYROID AGENTS                                                         
                     THIOAMIDES                                                                 
                     •  Methimazole         Inhibit thyroid peroxidase reactions   Hyperthyroidism  Oral • duration of action: 24 h
                     •  Propylthiouracil (PTU)  • block iodine organification • inhibit        (methimazole), 6–8 h (PTU) • delayed onset
                                            peripheral deiodination of T 4  and T 3            of action • Toxicity: Nausea, gastrointestinal
                                            (primarily PTU)                                    distress, rash, agranulocytosis, hepatitis
                                                                                               (PTU black box), hypothyroidism

                     IODIDES
                     •  Lugol’s solution    Inhibit organification and hormone   Preparation for surgical thyroidectomy  Oral • acute onset within 2–7 days • Toxicity:
                     •  Potassium iodide    release • reduce the size and                      Rare (see text)
                                            vascularity of the gland

                     BETA BLOCKERS
                     •   Propranolol, other β blockers   Inhibition of β adrenoreceptors   Hyperthyroidism, especially thyroid   Onset within hours • duration of 4–6 h (oral
                       lacking partial agonist activity  • inhibit T 4  to T 3  conversion (only   storm • adjunct to control tachycardia,   propranolol) • Toxicity: Asthma, AV
                                            propranolol)             hypertension, and atrial fibrillation  blockade, hypotension, bradycardia
                     RADIOACTIVE IODINE  131 I (RAI)                                            
                                            Radiation destruction of thyroid   Hyperthyroidism • patients should be   Oral • half-life 5 days • onset in 6–12 weeks
                                            parenchyma               euthyroid or on β blockers before   • maximum effect in 3–6 months • Toxicity:
                                                                     RAI • avoid in pregnancy and in   Sore throat, sialitis, hypothyroidism
                                                                     nursing mothers



                    PREP AR A TIONS                                      REFERENCES
                    A V AIL ABLE                                         General

                                                                         American Thyroid Association: Professional Guidelines. Available at: www.thyroid.
                            GENERIC NAME             AVAILABLE AS            org/professionals/ata-professional-guidelines/.
                                      THYROID AGENTS                     American Thyroid Association Task Force on Radiation Safety et al: Radiation
                                                                                                                        131
                     Levothyroxine (T 4 )       Generic, Levoxyl, Levo-T,    safety in the treatment of patients with thyroid diseases by radioiodine  I:
                                                                             Practice recommendations of the American Thyroid Association. Thyroid
                                                Levothroid, Levolet*,        2011;21:335.
                                                Novothyrox, Synthroid,   Chen AY et al: American Thyroid Association Statement on Optimal Surgical
                                                Tirosint (capsule), Unithroid
                                                                             Management of Goiter. Thyroid 2014;24:181.
                     Liothyronine (T 3 )        Generic, Cytomel, Triostat (IV)  Cooper DS, Ladenson PW: The thyroid gland. In: Gardner DG, Shoback D (editors):
                     Liotrix (a 4:1 ratio of T 4 : T 3 )  Thyrolar           Greenspan’s Basic & Clinical Endocrinology, 9th ed. McGraw-Hill, 2011.
                     Thyroid desiccated (USP)   Generic, Armour, Nature-  Haugen BR et al: 2015 American Thyroid Association Management Guidelines
                                                Throid, Westhroid            for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:
                                    ANTITHYROID AGENTS                       The  American  Thyroid  Association  Guidelines  Task  Force  on  Thyroid
                                                                             Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1.
                     Radioactive iodine ( 131 I) sodium  Iodotope, Sodium Iodide   Rugge JB, Bougatsos C, Chou R: Screening and treatment of thyroid dysfunction:
                                                I 131 Therapeutic            An evidence review for the U.S. Preventive Services Task Force. Ann Intern
                     Methimazole                Generic, Tapazole            Med. 2015;162:35.
                     Potassium iodide                                    U.S. Department of Health and Human Services: Potassium iodide as a
                       Oral solution (SSKI)     ThyroShield                  thyroid blocking agent in radiation emergencies. Available at:  www.fda.
                                                                             gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/
                       Oral solution (Lugol’s solution)  Lugol’s solution    UCM080542.pdf.
                       Oral potassium iodide tablets  IOSAT, Thyro-Block, Thyro-Safe
                     Propylthiouracil [PTU]     Generic                  Thyroid Hormone Action
                                     DIAGNOSTIC AGENT                    Chatterjee VK et al: Thyroid in 2012: Advances in thyroid development, hormone
                     Thyrotropin; recombinant human TSH  Thyrogen            action and neoplasia. Nat Rev Endocrinol 2013;9:74.
                                                                         Galli E, Pingitore A, Iervasi G: The role of thyroid hormone in the pathophysiology
                    * Not available in United States.
                                                                             of heart failure: Clinical evidence. Heart Fail Rev 2010;15:155.
   710   711   712   713   714   715   716   717   718   719   720